Matsuda A, Kuzuya T, Iwamoto Y, Yoshioka N, Awata T, Kumakura S, Ohwada N
Division of Endocrinology and Metabolism, Jichi Medical School, Tochigi-ken, Japan.
Diabetes Res Clin Pract. 1988 Jul 13;5(2):107-12. doi: 10.1016/s0168-8227(88)80049-4.
In order to discover the HLA DR antigens linked to Japanese insulin-dependent diabetes (IDDM), and to relate them to the clinical features, HLA DR antigens were examined in 75 IDDM patients including 56 adult-onset cases. Among the tested HLA DR antigens, 4, w9 and w13 were significantly more frequent in IDDM (55%, 47% and 27% respectively). The relative risk was 1.71 for DR4, 2.81 for DRw9 and 4.74 for DRw13. DR2 was significantly less frequent and the relative risk was 0.14. The distribution of DR antigens did not differ between juvenile-onset and adult-onset IDDM, males and females, or cases with and without thyroid autoantibodies. Homozygotes for DRw9 were, but those for DRw13 and DR4 were not more frequent than expected by a random combination. Heterozygotes for DR4 and w9 were less frequent while other heterozygotes for high-risk antigens were as frequent as expected. 97% of IDDM had either DR4, w9 or w13. In conclusion, HLA DR4, w9 and w13 were significantly increased in patients with both juvenile- and adult-onset IDDM. There was no surplus increase in the frequency of IDDM patients with two high-risk HLA DR antigens, more than expected from random combination of each of these DR antigens. Clinical features did not differ among IDDM patients with each of these three antigens.
为了发现与日本胰岛素依赖型糖尿病(IDDM)相关的HLA DR抗原,并将它们与临床特征联系起来,我们检测了75例IDDM患者(包括56例成年发病患者)的HLA DR抗原。在所检测的HLA DR抗原中,DR4、w9和w13在IDDM患者中显著更为常见(分别为55%、47%和27%)。DR4的相对风险为1.71,DRw9为2.81,DRw13为4.74。DR2显著较少见,相对风险为0.14。DR抗原的分布在青少年发病和成年发病的IDDM患者之间、男性和女性之间,以及有和没有甲状腺自身抗体的病例之间没有差异。DRw9的纯合子情况如此,但DRw13和DR4的纯合子并不比随机组合预期的更常见。DR4和w9的杂合子较少见,而其他高风险抗原的杂合子与预期的频率相同。97%的IDDM患者具有DR4、w9或w13。总之,青少年和成年发病的IDDM患者中HLA DR4、w9和w13显著增加。具有两种高风险HLA DR抗原的IDDM患者频率没有额外增加,超过了这些DR抗原各自随机组合的预期。具有这三种抗原中任何一种的IDDM患者的临床特征没有差异。